ADAR1 controls apoptosis of stressed cells by inhibiting Staufen1-mediated mRNA decay. 2017

Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
The Wistar Institute, Philadelphia, Pennsylvania, USA.

Both p150 and p110 isoforms of ADAR1 convert adenosine to inosine in double-stranded RNA (dsRNA). ADAR1p150 suppresses the dsRNA-sensing mechanism that activates MDA5-MAVS-IFN signaling in the cytoplasm. In contrast, the biological function of the ADAR1p110 isoform, which is usually located in the nucleus, is largely unknown. Here, we show that stress-activated phosphorylation of ADAR1p110 by MKK6-p38-MSK MAP kinases promotes its binding to Exportin-5 and its export from the nucleus. After translocating to the cytoplasm, ADAR1p110 suppresses apoptosis in stressed cells by protecting many antiapoptotic gene transcripts that contain 3'-untranslated-region dsRNA structures primarily comprising inverted Alu repeats. ADAR1p110 competitively inhibits binding of Staufen1 to the 3'-untranslated-region dsRNAs and antagonizes Staufen1-mediated mRNA decay. Our study reveals a new stress-response mechanism in which human ADAR1p110 and Staufen1 regulate surveillance of a set of mRNAs required for survival of stressed cells.

UI MeSH Term Description Entries
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D003598 Cytoskeletal Proteins Major constituent of the cytoskeleton found in the cytoplasm of eukaryotic cells. They form a flexible framework for the cell, provide attachment points for organelles and formed bodies, and make communication between parts of the cell possible. Proteins, Cytoskeletal
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000243 Adenosine Deaminase An enzyme that catalyzes the hydrolysis of ADENOSINE to INOSINE with the elimination of AMMONIA. Adenosine Aminohydrolase,Aminohydrolase, Adenosine,Deaminase, Adenosine
D013312 Stress, Physiological The unfavorable effect of environmental factors (stressors) on the physiological functions of an organism. Prolonged unresolved physiological stress can affect HOMEOSTASIS of the organism, and may lead to damaging or pathological conditions. Biotic Stress,Metabolic Stress,Physiological Stress,Abiotic Stress,Abiotic Stress Reaction,Abiotic Stress Response,Biological Stress,Metabolic Stress Response,Physiological Stress Reaction,Physiological Stress Reactivity,Physiological Stress Response,Abiotic Stress Reactions,Abiotic Stress Responses,Abiotic Stresses,Biological Stresses,Biotic Stresses,Metabolic Stress Responses,Metabolic Stresses,Physiological Stress Reactions,Physiological Stress Responses,Physiological Stresses,Reaction, Abiotic Stress,Reactions, Abiotic Stress,Response, Abiotic Stress,Response, Metabolic Stress,Stress Reaction, Physiological,Stress Response, Metabolic,Stress Response, Physiological,Stress, Abiotic,Stress, Biological,Stress, Biotic,Stress, Metabolic
D016601 RNA-Binding Proteins Proteins that bind to RNA molecules. Included here are RIBONUCLEOPROTEINS and other proteins whose function is to bind specifically to RNA. Double-Stranded RNA-Binding Protein,Double-Stranded RNA-Binding Proteins,ds RNA-Binding Protein,RNA-Binding Protein,ds RNA-Binding Proteins,Double Stranded RNA Binding Protein,Double Stranded RNA Binding Proteins,Protein, Double-Stranded RNA-Binding,Protein, ds RNA-Binding,RNA Binding Protein,RNA Binding Proteins,RNA-Binding Protein, Double-Stranded,RNA-Binding Protein, ds,RNA-Binding Proteins, Double-Stranded,ds RNA Binding Protein
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D020871 RNA Stability The extent to which an RNA molecule retains its structural integrity and resists degradation by RNASE, and base-catalyzed HYDROLYSIS, under changing in vivo or in vitro conditions. RNA Decay,mRNA Decay,mRNA Transcript Degradation,RNA Degradation,RNA Instability,mRNA Degradation,mRNA Instability,mRNA Stability,Decay, RNA,Decay, mRNA,Degradation, RNA,Degradation, mRNA,Degradation, mRNA Transcript,Instability, RNA,Instability, mRNA,Stability, RNA,Stability, mRNA,Transcript Degradation, mRNA
D020935 MAP Kinase Signaling System An intracellular signaling system involving the mitogen-activated protein kinase cascades (three-membered protein kinase cascades). Various upstream activators, which act in response to extracellular stimuli, trigger the cascades by activating the first member of a cascade, MAP KINASE KINASE KINASES; (MAPKKKs). Activated MAPKKKs phosphorylate MITOGEN-ACTIVATED PROTEIN KINASE KINASES which in turn phosphorylate the MITOGEN-ACTIVATED PROTEIN KINASES; (MAPKs). The MAPKs then act on various downstream targets to affect gene expression. In mammals, there are several distinct MAP kinase pathways including the ERK (extracellular signal-regulated kinase) pathway, the SAPK/JNK (stress-activated protein kinase/c-jun kinase) pathway, and the p38 kinase pathway. There is some sharing of components among the pathways depending on which stimulus originates activation of the cascade. MAP Kinase Cascade,MAP Kinase Module,MAP Kinase Signaling Cascade,MAP Kinase Signaling Pathway,MAP Kinase Signaling Pathways,ERK Pathway,ERK Signal Tranduction Pathway,ERK1 and ERK2 Pathway,ERK1-2 Pathway,JNK Pathway,JNK Signaling Pathway,MAP Kinase Modules,MAP Kinase Signaling Cascades,MEK-ERK Pathway,p38 Kinase Pathway,p38 Kinase Signaling Pathway,Cascade, MAP Kinase,ERK Pathways,ERK1 2 Pathway,ERK1-2 Pathways,JNK Pathways,JNK Signaling Pathways,Kinase Cascade, MAP,Kinase Pathway, p38,Kinase Pathways, p38,MAP Kinase Cascades,MEK ERK Pathway,MEK-ERK Pathways,Module, MAP Kinase,Pathway, ERK,Pathway, ERK1-2,Pathway, JNK,Pathway, JNK Signaling,Pathway, MEK-ERK,Pathway, p38 Kinase,Pathways, ERK,Pathways, ERK1-2,Pathways, JNK,Pathways, JNK Signaling,Pathways, MEK-ERK,Pathways, p38 Kinase,Signaling Pathway, JNK,Signaling Pathways, JNK,p38 Kinase Pathways

Related Publications

Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
October 2013, Nature structural & molecular biology,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
May 2012, Molecular cell,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
June 2014, Nucleic acids research,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
December 2013, Biochimica et biophysica acta,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
January 2018, Nature communications,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
December 2013, Immunologic research,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
July 2021, Oncogene,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
October 2022, Oncogene,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
November 2015, Cell death and differentiation,
Masayuki Sakurai, and Yusuke Shiromoto, and Hiromitsu Ota, and Chunzi Song, and Andrew V Kossenkov, and Jayamanna Wickramasinghe, and Louise C Showe, and Emmanuel Skordalakes, and Hsin-Yao Tang, and David W Speicher, and Kazuko Nishikura
June 2020, Molecular therapy. Nucleic acids,
Copied contents to your clipboard!